Deregulated Drosha levels—whether due to regulatory SNPs, structural variants, or deletions—may impair miRNA biogenesis and disrupt the tightly regulated balance between oncogenic and tumor-suppressor miRNAs. Here, DROSHA is linked to neoplasm.